Can We Talk About Big Pharma Without Alienating Disabled People?

A handful of companies in the world control the vast majority of pharmaceutical patents, and maintain a stranglehold on the market for life-saving and critical medications, most of which remain highly priced as long as they’re on patent. When patents finally expire, the scramble for generic competition begins, while pharmaceutical firms sink new resources into […]